Cite
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.
MLA
Parry, Helen, et al. “COVID-19 Vaccines Elicit Robust Cellular Immunity and Clinical Protection in Chronic Lymphocytic Leukemia.” Cancer Cell, vol. 40, no. 6, June 2022, pp. 584–86. EBSCOhost, https://doi.org/10.1016/j.ccell.2022.05.001.
APA
Parry, H., Bruton, R., Roberts, T., McIlroy, G., Damery, S., Sylla, P., Dowell, A. C., Tut, G., Lancaster, T., Bone, D., Willett, B., Logan, N., Scott, S., Hulme, S., Jadir, A., Amin, U., Nicol, S., Stephens, C., Faustini, S., … Moss, P. (2022). COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia. Cancer Cell, 40(6), 584–586. https://doi.org/10.1016/j.ccell.2022.05.001
Chicago
Parry, Helen, Rachel Bruton, Thomas Roberts, Graham McIlroy, Sarah Damery, Panagiota Sylla, Alexander C Dowell, et al. 2022. “COVID-19 Vaccines Elicit Robust Cellular Immunity and Clinical Protection in Chronic Lymphocytic Leukemia.” Cancer Cell 40 (6): 584–86. doi:10.1016/j.ccell.2022.05.001.